Log in
Enquire now
Embera NeuroTherapeutics

Embera NeuroTherapeutics

Embera NeuroTherapeutics is a smoking cessation and cocaine dependence therapeutics company founded by Bob Linke, Michael Short, Carol Gloff, Nicholas Goeders and Douglas Feltner.

OverviewStructured DataIssuesContributors

Contents

emberaneuro.com
Is a
Organization
Organization
Company
Company

Company attributes

Industry
Engineering
Engineering
Technology
Technology
Biology
Biology
Biotechnology
Biotechnology
Biomedical engineering
Biomedical engineering
Location
Boston
Boston
B2X
B2C
B2C
0
B2B
B2B
0
Founder
‌
Carol Gloff
Bob Linke
Bob Linke
Michael Short
Michael Short
Nicholas Goeders
Nicholas Goeders
‌
Douglas Feltner
AngelList URL
angel.co/embera-neu...herapeutics
Pitchbook URL
pitchbook.com/profiles.../52652-26
Investors
Louisiana Fund I
Louisiana Fund I
Ariel Savannah Angel Partners
Ariel Savannah Angel Partners
Total Funding Amount (USD)
4,500,000
Latest Funding Round Date
August 14, 2011
Board of Directors
‌
Ross P. Barrett
0
0
Latest Funding Type
Series A
Series A
COO
0
Wellfound ID
embera-neurotherapeutics
Country
United States
United States

Other attributes

Company Operating Status
Active
COO of
Embera NeuroTherapeutics
Embera NeuroTherapeutics
No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like Embera NeuroTherapeutics

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.